Global and United States Self-administered Drugs Market Insights, Forecast to 2026

Publisher Name :
Date: 24-Sep-2020
No. of pages: 128
Inquire Before Buying

Self-administered Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Self-administered Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Self-administered Drugs market is segmented into

- Injectable Drugs

- Inhaled Drugs

- Transdermal Drugs

Segment by Application, the Self-administered Drugs market is segmented into

- Cardiovascular Diseases

- Diabetes

- Osteoporosis

- Pain Management

- Hormone Replacement

- Others

Regional and Country-level Analysis

The Self-administered Drugs market is analysed and market size information is provided by regions (countries).

The key regions covered in the Self-administered Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Self-administered Drugs Market Share Analysis

Self-administered Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Self-administered Drugs business, the date to enter into the Self-administered Drugs market, Self-administered Drugs product introduction, recent developments, etc.

The major vendors covered:

- Abbott Laboratories

- Bristol-Myers Squibb

- Novartis AG

- Eli Lilly and Company

- Gilead Sciences

- Antares Pharma

- ...

Global and United States Self-administered Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Self-administered Drugs Product Introduction
1.2 Market Segments
1.3 Key Self-administered Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Self-administered Drugs Market Size Growth Rate by Type
1.4.2 Injectable Drugs
1.4.3 Inhaled Drugs
1.4.4 Transdermal Drugs
1.5 Market by Application
1.5.1 Global Self-administered Drugs Market Size Growth Rate by Application
1.5.2 Cardiovascular Diseases
1.5.3 Diabetes
1.5.4 Osteoporosis
1.5.5 Pain Management
1.5.6 Hormone Replacement
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Self-administered Drugs Market Size, Estimates and Forecasts
2.1.1 Global Self-administered Drugs Revenue 2015-2026
2.1.2 Global Self-administered Drugs Sales 2015-2026
2.2 Global Self-administered Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Self-administered Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Self-administered Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Self-administered Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Self-administered Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Self-administered Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Self-administered Drugs Revenue Forecast by Region (2021-2026)
3 Global Self-administered Drugs Competitor Landscape by Players
3.1 Global Top Self-administered Drugs Sales by Manufacturers
3.1.1 Global Self-administered Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Self-administered Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Self-administered Drugs Manufacturers by Revenue
3.2.1 Global Self-administered Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Self-administered Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Self-administered Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Self-administered Drugs Revenue in 2019
3.2.5 Global Self-administered Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Self-administered Drugs Price by Manufacturers
3.4 Global Self-administered Drugs Manufacturing Base Distribution, Product Types
3.4.1 Self-administered Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Self-administered Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Self-administered Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Self-administered Drugs Market Size by Type (2015-2020)
4.1.1 Global Self-administered Drugs Sales by Type (2015-2020)
4.1.2 Global Self-administered Drugs Revenue by Type (2015-2020)
4.1.3 Self-administered Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Self-administered Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Self-administered Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Self-administered Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Self-administered Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Self-administered Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Self-administered Drugs Market Size by Application (2015-2020)
5.1.1 Global Self-administered Drugs Sales by Application (2015-2020)
5.1.2 Global Self-administered Drugs Revenue by Application (2015-2020)
5.1.3 Self-administered Drugs Price by Application (2015-2020)
5.2 Self-administered Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Self-administered Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Self-administered Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Self-administered Drugs Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Self-administered Drugs Market Size YoY Growth 2015-2026
6.1.1 United States Self-administered Drugs Sales YoY Growth 2015-2026
6.1.2 United States Self-administered Drugs Revenue YoY Growth 2015-2026
6.1.3 United States Self-administered Drugs Market Share in Global Market 2015-2026
6.2 United States Self-administered Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Self-administered Drugs Players by Sales (2015-2020)
6.2.2 United States Top Self-administered Drugs Players by Revenue (2015-2020)
6.3 United States Self-administered Drugs Historic Market Review by Type (2015-2020)
6.3.1 United States Self-administered Drugs Sales Market Share by Type (2015-2020)
6.3.2 United States Self-administered Drugs Revenue Market Share by Type (2015-2020)
6.3.3 United States Self-administered Drugs Price by Type (2015-2020)
6.4 United States Self-administered Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Self-administered Drugs Sales Forecast by Type (2021-2026)
6.4.2 United States Self-administered Drugs Revenue Forecast by Type (2021-2026)
6.4.3 United States Self-administered Drugs Price Forecast by Type (2021-2026)
6.5 United States Self-administered Drugs Historic Market Review by Application (2015-2020)
6.5.1 United States Self-administered Drugs Sales Market Share by Application (2015-2020)
6.5.2 United States Self-administered Drugs Revenue Market Share by Application (2015-2020)
6.5.3 United States Self-administered Drugs Price by Application (2015-2020)
6.6 United States Self-administered Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Self-administered Drugs Sales Forecast by Application (2021-2026)
6.6.2 United States Self-administered Drugs Revenue Forecast by Application (2021-2026)
6.6.3 United States Self-administered Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Self-administered Drugs Market Size YoY Growth 2015-2026
7.2 North America Self-administered Drugs Market Facts & Figures by Country
7.2.1 North America Self-administered Drugs Sales by Country (2015-2020)
7.2.2 North America Self-administered Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Self-administered Drugs Market Size YoY Growth 2015-2026
8.2 Europe Self-administered Drugs Market Facts & Figures by Country
8.2.1 Europe Self-administered Drugs Sales by Country
8.2.2 Europe Self-administered Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Self-administered Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Self-administered Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Self-administered Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Self-administered Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Self-administered Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Self-administered Drugs Market Facts & Figures by Country
10.2.1 Latin America Self-administered Drugs Sales by Country
10.2.2 Latin America Self-administered Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Self-administered Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Self-administered Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Self-administered Drugs Sales by Country
11.2.2 Middle East and Africa Self-administered Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Corporation Information
12.1.2 Abbott Laboratories Description and Business Overview
12.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Abbott Laboratories Self-administered Drugs Products Offered
12.1.5 Abbott Laboratories Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Corporation Information
12.2.2 Bristol-Myers Squibb Description and Business Overview
12.2.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bristol-Myers Squibb Self-administered Drugs Products Offered
12.2.5 Bristol-Myers Squibb Recent Development
12.3 Novartis AG
12.3.1 Novartis AG Corporation Information
12.3.2 Novartis AG Description and Business Overview
12.3.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis AG Self-administered Drugs Products Offered
12.3.5 Novartis AG Recent Development
12.4 Eli Lilly and Company
12.4.1 Eli Lilly and Company Corporation Information
12.4.2 Eli Lilly and Company Description and Business Overview
12.4.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Eli Lilly and Company Self-administered Drugs Products Offered
12.4.5 Eli Lilly and Company Recent Development
12.5 Gilead Sciences
12.5.1 Gilead Sciences Corporation Information
12.5.2 Gilead Sciences Description and Business Overview
12.5.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Gilead Sciences Self-administered Drugs Products Offered
12.5.5 Gilead Sciences Recent Development
12.6 Antares Pharma
12.6.1 Antares Pharma Corporation Information
12.6.2 Antares Pharma Description and Business Overview
12.6.3 Antares Pharma Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Antares Pharma Self-administered Drugs Products Offered
12.6.5 Antares Pharma Recent Development
12.11 Abbott Laboratories
12.11.1 Abbott Laboratories Corporation Information
12.11.2 Abbott Laboratories Description and Business Overview
12.11.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Abbott Laboratories Self-administered Drugs Products Offered
12.11.5 Abbott Laboratories Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Self-administered Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Self-administered Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Self-administered Drugs Market Segments
Table 2. Ranking of Global Top Self-administered Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Self-administered Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Injectable Drugs
Table 5. Major Manufacturers of Inhaled Drugs
Table 6. Major Manufacturers of Transdermal Drugs
Table 7. Global Self-administered Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Self-administered Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Self-administered Drugs Sales by Regions 2015-2020 (K MT)
Table 10. Global Self-administered Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Self-administered Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Self-administered Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 13. Global Self-administered Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Self-administered Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Self-administered Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Self-administered Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Self-administered Drugs as of 2019)
Table 17. Self-administered Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Self-administered Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Self-administered Drugs Price (2015-2020) (USD/MT)
Table 20. Self-administered Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Self-administered Drugs Product Type
Table 22. Date of International Manufacturers Enter into Self-administered Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Self-administered Drugs Sales by Type (2015-2020) (K MT)
Table 25. Global Self-administered Drugs Sales Share by Type (2015-2020)
Table 26. Global Self-administered Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Self-administered Drugs Revenue Share by Type (2015-2020)
Table 28. Self-administered Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Self-administered Drugs Sales Share by Type (2021-2026)
Table 30. Global Self-administered Drugs Sales by Application (2015-2020) (K MT)
Table 31. Global Self-administered Drugs Sales Share by Application (2015-2020)
Table 32. Global Self-administered Drugs Sales Share by Application (2021-2026)
Table 33. Global Self-administered Drugs Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Self-administered Drugs Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Self-administered Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 36. United States Self-administered Drugs Sales (K MT) of Key Companies (2015-2020)
Table 37. United States Self-administered Drugs Sales Share by Company (2015-2020)
Table 38. United States Self-administered Drugs Revenue (US$ Million) by Company (2015-2020)
Table 39. United States Self-administered Drugs Sales (K MT) by Type (2015-2020)
Table 40. United States Self-administered Drugs Sales Share by Type (2015-2020)
Table 41. United States Self-administered Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. United States Self-administered Drugs Price (K MT) by Type (2015-2020)
Table 43. United States Self-administered Drugs Sales (K MT) by Type (2021-2026)
Table 44. United States Self-administered Drugs Sales Share by Type (2021-2026)
Table 45. United States Self-administered Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. United States Self-administered Drugs Revenue Share by Type (2021-2026)
Table 47. United States Self-administered Drugs Price (K MT) by Type (2021-2026)
Table 48. United States Self-administered Drugs Sales (K MT) by Application (2015-2020)
Table 49. United States Self-administered Drugs Sales Share by Application (2015-2020)
Table 50. United States Self-administered Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. United States Self-administered Drugs Sales (K MT) by Application (2021-2026)
Table 52. United States Self-administered Drugs Sales Share by Application (2021-2026)
Table 53. United States Self-administered Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. United States Self-administered Drugs Revenue Share by Application (2021-2026)
Table 55. North America Self-administered Drugs Sales by Country (2015-2020) (K MT)
Table 56. North America Self-administered Drugs Sales Market Share by Country (2015-2020)
Table 57. North America Self-administered Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Self-administered Drugs Revenue Market Share by Country (2015-2020)
Table 59. Europe Self-administered Drugs Sales by Country (2015-2020) (K MT)
Table 60. Europe Self-administered Drugs Sales Market Share by Country (2015-2020)
Table 61. Europe Self-administered Drugs Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Self-administered Drugs Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Self-administered Drugs Sales by Region (2015-2020) (K MT)
Table 64. Asia Pacific Self-administered Drugs Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Self-administered Drugs Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Self-administered Drugs Revenue Market Share by Region (2015-2020)
Table 67. Latin America Self-administered Drugs Sales by Country (2015-2020) (K MT)
Table 68. Latin America Self-administered Drugs Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Self-administered Drugs Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Self-administered Drugs Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Self-administered Drugs Sales by Country (2015-2020) (K MT)
Table 72. Middle East and Africa Self-administered Drugs Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Self-administered Drugs Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Self-administered Drugs Revenue Market Share by Country (2015-2020)
Table 75. Abbott Laboratories Corporation Information
Table 76. Abbott Laboratories Description and Business Overview
Table 77. Abbott Laboratories Self-administered Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Abbott Laboratories Self-administered Drugs Product
Table 79. Abbott Laboratories Recent Development
Table 80. Bristol-Myers Squibb Corporation Information
Table 81. Bristol-Myers Squibb Description and Business Overview
Table 82. Bristol-Myers Squibb Self-administered Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Bristol-Myers Squibb Product
Table 84. Bristol-Myers Squibb Recent Development
Table 85. Novartis AG Corporation Information
Table 86. Novartis AG Description and Business Overview
Table 87. Novartis AG Self-administered Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Novartis AG Product
Table 89. Novartis AG Recent Development
Table 90. Eli Lilly and Company Corporation Information
Table 91. Eli Lilly and Company Description and Business Overview
Table 92. Eli Lilly and Company Self-administered Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Eli Lilly and Company Product
Table 94. Eli Lilly and Company Recent Development
Table 95. Gilead Sciences Corporation Information
Table 96. Gilead Sciences Description and Business Overview
Table 97. Gilead Sciences Self-administered Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Gilead Sciences Product
Table 99. Gilead Sciences Recent Development
Table 100. Antares Pharma Corporation Information
Table 101. Antares Pharma Description and Business Overview
Table 102. Antares Pharma Self-administered Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Antares Pharma Product
Table 104. Antares Pharma Recent Development
Table 105. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 106. Key Challenges
Table 107. Market Risks
Table 108. Main Points Interviewed from Key Self-administered Drugs Players
Table 109. Self-administered Drugs Customers List
Table 110. Self-administered Drugs Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Self-administered Drugs Product Picture
Figure 2. Global Self-administered Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Injectable Drugs Product Picture
Figure 4. Inhaled Drugs Product Picture
Figure 5. Transdermal Drugs Product Picture
Figure 6. Global Self-administered Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Cardiovascular Diseases
Figure 8. Diabetes
Figure 9. Osteoporosis
Figure 10. Pain Management
Figure 11. Hormone Replacement
Figure 12. Others
Figure 13. Self-administered Drugs Report Years Considered
Figure 14. Global Self-administered Drugs Market Size 2015-2026 (US$ Million)
Figure 15. Global Self-administered Drugs Sales 2015-2026 (K MT)
Figure 16. Global Self-administered Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Self-administered Drugs Sales Market Share by Region (2015-2020)
Figure 18. Global Self-administered Drugs Sales Market Share by Region in 2019
Figure 19. Global Self-administered Drugs Revenue Market Share by Region (2015-2020)
Figure 20. Global Self-administered Drugs Revenue Market Share by Region in 2019
Figure 21. Global Self-administered Drugs Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Self-administered Drugs Revenue in 2019
Figure 23. Self-administered Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Self-administered Drugs Sales Market Share by Type (2015-2020)
Figure 25. Global Self-administered Drugs Sales Market Share by Type in 2019
Figure 26. Global Self-administered Drugs Revenue Market Share by Type (2015-2020)
Figure 27. Global Self-administered Drugs Revenue Market Share by Type in 2019
Figure 28. Global Self-administered Drugs Market Share by Price Range (2015-2020)
Figure 29. Global Self-administered Drugs Sales Market Share by Application (2015-2020)
Figure 30. Global Self-administered Drugs Sales Market Share by Application in 2019
Figure 31. Global Self-administered Drugs Revenue Market Share by Application (2015-2020)
Figure 32. Global Self-administered Drugs Revenue Market Share by Application in 2019
Figure 33. United States Self-administered Drugs Sales Growth Rate 2015-2026 (K MT)
Figure 34. United States Self-administered Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. United States Self-administered Drugs Market Share in Global Market 2015-2026
Figure 36. United States 5 and 10 Largest Self-administered Drugs Players Market Share by Revenue in Self-administered Drugs in 2019
Figure 37. United States Self-administered Drugs Revenue Share by Type (2015-2020)
Figure 38. United States Self-administered Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 39. United States Self-administered Drugs Revenue Share by Application (2015-2020)
Figure 40. United States Self-administered Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 41. North America Self-administered Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 42. North America Self-administered Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America Self-administered Drugs Sales Market Share by Country in 2019
Figure 44. North America Self-administered Drugs Revenue Market Share by Country in 2019
Figure 45. U.S. Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 46. U.S. Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 48. Canada Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe Self-administered Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 50. Europe Self-administered Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Self-administered Drugs Sales Market Share by Country in 2019
Figure 52. Europe Self-administered Drugs Revenue Market Share by Country in 2019
Figure 53. Germany Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 54. Germany Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 56. France Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 58. U.K. Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 60. Italy Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 62. Russia Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Asia Pacific Self-administered Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 64. Asia Pacific Self-administered Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Self-administered Drugs Sales Market Share by Region in 2019
Figure 66. Asia Pacific Self-administered Drugs Revenue Market Share by Region in 2019
Figure 67. China Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 68. China Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 70. Japan Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 72. South Korea Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 74. India Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 76. Australia Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwan Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Taiwan Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Indonesia Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 80. Indonesia Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Thailand Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 82. Thailand Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Malaysia Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 84. Malaysia Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Philippines Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 86. Philippines Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Vietnam Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 88. Vietnam Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Latin America Self-administered Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 90. Latin America Self-administered Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Self-administered Drugs Sales Market Share by Country in 2019
Figure 92. Latin America Self-administered Drugs Revenue Market Share by Country in 2019
Figure 93. Mexico Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 94. Mexico Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 96. Brazil Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 98. Argentina Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Middle East and Africa Self-administered Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 100. Middle East and Africa Self-administered Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Self-administered Drugs Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Self-administered Drugs Revenue Market Share by Country in 2019
Figure 103. Turkey Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 104. Turkey Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 106. Saudi Arabia Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Self-administered Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 108. U.A.E Self-administered Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Porter's Five Forces Analysis
Figure 110. Self-administered Drugs Value Chain
Figure 111. Channels of Distribution
Figure 112. Distributors Profiles
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed
  • Investigation Report on Chinese Hydroxychloroquine (HCQ) Market, 2020-2024
    Published: 20-Oct-2020        Price: US 2600 Onwards        Pages: 50
    Description Hydroxychloroquine(HCQ) is an antimalarial drug. It treats malaria by killing the parasites that cause the disease. Hydroxychloroquine was listed in the United States in 1955, and the original research drug manufacturer was Sanofi. Hydroxychloroquine has been listed in Canada, France, Germany, Australia, China, Japan and other countries, and many companies worldwide have produced generic drugs of hydroxychloroquine. The indications for hydroxychloroquine include malari......
  • Global and Japan Human Immunoglobulin Market Insights, Forecast to 2026
    Published: 19-Oct-2020        Price: US 3900 Onwards        Pages: 144
    Human Immunoglobulin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Human Immunoglobulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Human Immunoglobulin market is ......
  • (COVID-19 Version) Global Primary Immunodeficiency Diseases Treatment Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 18-Oct-2020        Price: US 3000 Onwards        Pages: 90
    Summary The report forecast global Primary Immunodeficiency Diseases Treatment market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Primary Immunodeficiency Diseases Treatment industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company sh......
  • (COVID-19 Version) Global Primary Biliary Cirrhosis Drug Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 18-Oct-2020        Price: US 3000 Onwards        Pages: 98
    Summary The report forecast global Primary Biliary Cirrhosis Drug market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Primary Biliary Cirrhosis Drug industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Primar......
  • (COVID-19 Version) Global Prednisone Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 18-Oct-2020        Price: US 3000 Onwards        Pages: 102
    Summary The report forecast global Prednisone market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Prednisone industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Prednisone by geography. The report splits the......
  • COVID-19 World Solid Organ Transplant Immunosuppressant Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 18-Oct-2020        Price: US 2800 Onwards        Pages: 92
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Solid Organ Transplant Immunosuppressant......
  • COVID-19 World Oral Vaccines Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 16-Oct-2020        Price: US 2800 Onwards        Pages: 135
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Oral Vaccines , covering Global total an......
  • COVID-19 World Methyl Salicylate Patches Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 16-Oct-2020        Price: US 2800 Onwards        Pages: 102
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Methyl Salicylate Patches , covering Glo......
  • COVID-19 World Meningitis Vaccine Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 16-Oct-2020        Price: US 2800 Onwards        Pages: 100
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Meningitis Vaccine , covering Global tot......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs